Arvinas (ARVN) Other Working Capital Changes (2017 - 2026)
Arvinas' (ARVN) quarterly Other Working Capital Changes came in at -$15.6 million in Q1 2026, down 3020.0% year-on-year from $534246.6 in Q1 2025, and up 93.53% quarter-over-quarter from -$241.0 million in Q4 2025.
Arvinas (ARVN) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Arvinas' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$15.6 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 3020.0% year-over-year to -$15.6 million in Q1 2026; TTM through Mar 2026 was -$257.7 million, a 155.15% decrease from a year earlier, with the FY2025 full-year figure at -$242.6 million, down 140.2% from the prior year.
- Other Working Capital Changes advanced to -$15.6 million in Q1 2026 per ARVN's latest filing, from -$241.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.1 million in Q2 2024 and bottomed at -$6.9 million in Q1 2023.
- The 5-year median for Other Working Capital Changes is $400000.0 (2024), against an average of -$588235.3.
- Across the five-year window, Other Working Capital Changes slumped 18175.0% in 2023 and surged 10200.0% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$400000.0 in 2022, then slumped by 18175.0% to -$73.1 million in 2023, then tumbled by 35.98% to -$99.4 million in 2024, then plunged by 142.45% to -$241.0 million in 2025, then surged by 93.53% to -$15.6 million in 2026.
- Per Business Quant, the three latest ARVN Other Working Capital Changes figures stand at -$15.6 million (Q1 2026), -$241.0 million (Q4 2025), and $209.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Mar 31, 2026 | 600,000.00 |
| Mar 31, 2026 | 600,000.00 |
| Dec 31, 2025 | -3.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |